MedTrace Logo

Cardiac Performance System Data Collection Study

NCT05866666 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2023-11-21

No results posted yet for this study

Summary

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Conditions

  • Cardiac Disease

Interventions

DEVICE

Cardiac Performance System (NSR)

Participants will be asked to wear the Cardiac Performance System, a non-invasive sensor device on their upper abdomen. The Cardiac Performance System monitoring device will continuously monitor cardiac function.

Sponsors & Collaborators

  • Orlando Health, Inc.

    collaborator OTHER

  • Sensydia Corporation

    lead INDUSTRY

Principal Investigators

  • Yahaira Ortiz-Gonzalez, MD · Orlando Health

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-30
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05866666 on ClinicalTrials.gov